ESMO Breast Cancer 2023 Congress Coverage

 

ESMO Breast Cancer 2023 Congress Coverage
K

ESMO Breast Cancer 2023 Phase 3b LUCY Trial Subgroup Analysis: Clinical Effectiveness of Olaparib in BRCAm, HER2- mBC by ER Expression Level

By ESMO Breast Cancer 2023 Congress Coverage FEATURING Karen Gelmon
By ESMO Breast Cancer 2023 Congress Coverage FEATURING Karen Gelmon
106 views
May 25, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

03:15
Lilly Medical Affairs

Unmet Needs and Resistance Mechanisms in Patients With HR+, HER2- MB…

Feat. W. Mchayleh

Featured Video

11:11
Lilly Medical Affairs

Supporting Patients With Breast Cancer in the Clinic: Setting the Pa…

Feat. S. Dawood
Videos
19:34

ESMO Breast Cancer 2023 Clinical Impact of Evolving ADC Technology

ESMO Breast Cancer 2023 Congress Coverage

H. McArthur

161 views
10:48

ESMO Breast Cancer 2023 Results of Part B of SOLTI TOT-HER3 Window o…

ESMO Breast Cancer 2023 Congress Coverage

M. Oliveira

307 views
16:20

ESMO Breast Cancer 2023: Role of Germline Genetic Testing in Early B…

ESMO Breast Cancer 2023 Congress Coverage

S. Lee

122 views
07:49

ESMO Breast Cancer 2023 KEYNOTE-355 Trial: Outcomes in TNBC Patients…

ESMO Breast Cancer 2023 Congress Coverage

H. Rugo

868 views
17:44

ESMO Breast Cancer 2023 Phase 3 DESTINY-Breast04 Trial Safety Analys…

ESMO Breast Cancer 2023 Congress Coverage

H. Rugo

51 views
14:38

ESMO Breast Cancer 2023 Phase 3b LUCY Trial Subgroup Analysis: Clini…

ESMO Breast Cancer 2023 Congress Coverage

K. Gelmon

106 views
17:03

ESMO Breast Cancer 2023 Clinical Implementation of Oral SERD: Presen…

ESMO Breast Cancer 2023 Congress Coverage

C. Criscitiello

263 views
10:06

ESMO Breast Cancer 2023 DORA Phase 2 Study: Durvalumab and Olaparib …

ESMO Breast Cancer 2023 Congress Coverage

T. Tan

51 views
14:11

ESMO Breast Cancer 2023 Highlights: Key Studies Including IMPassion0…

ESMO Breast Cancer 2023 Congress Coverage

P. Tarantino

768 views
16:58

ESMO Breast Cancer 2023: Who Really Benefits From IO? Can We Identif…

ESMO Breast Cancer 2023 Congress Coverage

J. Balko

45 views
09:56

ESMO Breast Cancer 2023 EMERALD Trial: Analysis of PROs in Patients …

ESMO Breast Cancer 2023 Congress Coverage

J. Cortes

502 views
05:47

ESMO Breast Cancer 2023 DATA Trial Analysis: The Prognostic and Pred…

ESMO Breast Cancer 2023 Congress Coverage

S. Lammers

54 views